CONWX
Price
$18.31
Change
+$0.09 (+0.49%)
Updated
Jan 30 closing price
Net Assets
40.86M
RLEFX
Price
$35.37
Change
+$0.24 (+0.68%)
Updated
Jan 30 closing price
Net Assets
241.03B
Ad is loading...

CONWX vs RLEFX

Header iconCONWX vs RLEFX Comparison
Open Charts CONWX vs RLEFXBanner chart's image
Concorde Wealth Management
Price$18.31
Change+$0.09 (+0.49%)
VolumeN/A
Net Assets40.86M
American Funds American Balanced R5E
Price$35.37
Change+$0.24 (+0.68%)
VolumeN/A
Net Assets241.03B
CONWX vs RLEFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CONWX vs. RLEFX commentary
Jan 31, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CONWX is a StrongBuy and RLEFX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RLEFX has more cash in the bank: 241B vs. CONWX (40.9M). RLEFX pays higher dividends than CONWX: RLEFX (2.42) vs CONWX (2.04). CONWX was incepted earlier than RLEFX: CONWX (37 years) vs RLEFX (9 years). RLEFX is a more actively managed with annual turnover of: 171.00 vs. CONWX (28.00). RLEFX has a lower initial minimum investment than CONWX: RLEFX (250) vs CONWX (500). RLEFX annual gain was more profitable for investors over the last year : 12.30 vs. CONWX (7.70). RLEFX return over 5 years is better than : 34.94 vs. CONWX (20.28).
CONWXRLEFXCONWX / RLEFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence37 years9 years-
Gain YTD2.5323.12081%
Front LoadN/AN/A-
Min. Initial Investment500250200%
Min. Initial Investment IRAN/AN/A-
Net Assets40.9M241B0%
Annual Yield % from dividends2.042.4284%
Returns for 1 year7.7012.3063%
Returns for 3 years-1.0915.20-7%
Returns for 5 years20.2834.9458%
Returns for 10 years30.24N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IPAR143.293.26
+2.33%
Interparfums Inc
ACGL94.580.76
+0.81%
Arch Capital Group Ltd
DSGN4.970.03
+0.61%
Design Therapeutics
GENI8.940.04
+0.45%
Genius Sports Limited
XLO0.69-0.02
-2.88%
Xilio Therapeutics